Platelet-activating factor-mediated endosome formation causes membrane translocation of p67phox and p40phox that requires recruitment and activation of p38 MAPK, Rab5a, and phosphatidylinositol 3-kinase in human neutrophils

Journal of Immunology

Volumn 180, Issue 12, 2008, Pages 8192-8203

  McLaughlin, Nathan J D ^a,b   Banerjee, Anirban ^c   Khan, Samina Y ^a,b   Lieber, Janet L ^d   Kelher, Marguerite R ^a,c   Gamboni Robertson, Fabia ^c   Sheppard, Forest R ^c   Moore, Ernest E ^c   Mierau, Gary W ^d   Elzi, David J ^a,c   Silliman, Christopher C ^a,b,c,e  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d CHILDREN S HOSPITAL   (United States)

^e Bonfils Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIN II; EARLY ENDOSOME ANTIGEN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; RAB5A PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P40PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P67PHOX; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; LIGAND; NEUTROPHIL CYTOSOL FACTOR 40K; NEUTROPHIL CYTOSOL FACTOR 67K; PHOSPHOPROTEIN; RAB PROTEIN; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; VESICULAR TRANSPORT PROTEIN;

ARTICLE; CELL MEMBRANE; ENDOSOME; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ENZYMOLOGY; FLUORESCENCE RESONANCE ENERGY TRANSFER; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL MEMBRANE; DYNAMIN II; ENDOSOMES; ENZYME ACTIVATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LIGANDS; MAP KINASE SIGNALING SYSTEM; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN TRANSPORT; RAB5 GTP-BINDING PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; VESICULAR TRANSPORT PROTEINS;

EID: 50949132535     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.12.8192     Document Type: Article

References (91)

1. Conner, S. D., and S. L. Schmid. 2003. Regulated portals of entry into the cell. Nature 422: 37-44.
2. Luttrell, L. M., Y. Daaka, and R. J. Lefkowitr. 1999. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11: 177-183.
3. Gaidarov, I., F. Santini, R. A. Warren, and J. H. Keen. 1999. Spatial control of coated-pit dynamics in living cells. Nat. Cell Biol. 1: 1-7.
4. McLaughlin, N. J., A. Banerjee, M. R. Kelher, F. Gamboni-Robertson, C. Hamiel, F. R. Sheppard, E. E. Moore, and C. C. Silliman. 2006. Platelet-activating factor-induced clathrin-mediated endocytosis requires β-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. J. Immunol. 176: 7039-7050.
5. Marsh, M., and H. T. McMahon. 1999. The structural era of endocytosis. Science 285: 215-220.
6. Robinson, M. S., and J. S. Bonifacino. 2001. Adaptor-related proteins. Curr. Opin. Cell Biol. 13: 444-453.
7. Hinshaw, J. E., and S. L. Schmid. 1995. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding. Nature 374: 190-192.
8. Sever, S., H. Damke, and S. L. Schmid. 2000. Garrotes, springs, ratchets, and whips: putting dynamin models to the test. Traffic 1: 385-392.
9. Stowell, M. H., B. Marks, P. Wigge, and H. T. McMahon. 1999. Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring. Nat. Cell Biol. 1: 27-32.
10. Sweitzer, S. M., and J. E. Hinshaw. 1998. Dynamin undergoes a GTP-dependent conformational change causing vesiculation. Cell 93: 1021-1029.
11. Clague, M. J. 1999. Membrane transport: take your fusion partners. Curr. Biol. 9: R258-R260.
12. Gorvel, J. P., P. Chavrier, M. Zerial, and J. Gruenberg. 1991. rab5 controls early endosome fusion in vitro. Cell 64: 915-925.
13. Nielsen, E., F. Severin, J. M. Backer, A. A. Hyman, and M. Zerial. 1999. Rab5 regulates motility of early endosomes on microtubules. Nat. Cell Biol. 1: 376-382.
14. Lawe, D. C., A. Chawla, E. Merithew, J. Dumas, W. Carrington, K. Fogarty, L. Lifshitz, R. Tuft, D. Lambright, and S. Corvera. 2002. Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1. J. Biol. Chem. 277: 8611-8617.
15. Albelda, S. M., C. W. Smith, and P. A. Ward. 1994. Adhesion molecules and inflammatory injury. FASEB J. 8: 504-512.
16. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101.
17. Clague, M. J., and S. Urbe. 2001. The interface of receptor trafficking and signalling. J. Cell Sci. 114: 3075-3081.
18. DeLeo, F. R., J. Renee, S. McCormick, M. Nakamura, M. Apicella, J. P. Weiss, and W. M. Nauseef. 1998. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J. Clin. Invest. 101: 455-463.
19. phox is a common event of priming of human neutrophils by TNF-α and granulocyte-macrophage colony-stimulating factor. J. Immunol. 171: 4392-4398.
20. Shalit, M., G. A. Dabiri, and F. S. Southwick. 1987. Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly. Blood 70: 1921-1927.
21. Silliman, C. C., D. J. Elzi, D. R. Ambruso, R. J. Musters, C. Hamiel, R. J. Harbeck, A. J. Paterson, A. J. Bjornsen, T. H. Wyman, M. Kelher, et al. 2003. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J. Leukocyte Biol. 73: 511-524.
22. Vercellotti, G. M., H. Q. Yin, K. S. Gustafson, R. D. Nelson, and H. S. Jacob. 1988. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 71: 1100-1107.
23. Wyman, T. H., C. A. Dinarello, A. Banerjee, F. Gamboni-Robertson, A. A. Hiester, K. M. England, M. Kelher, and C. C. Silliman. 2002. Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation. J. Leukocyte Biol. 72: 401-409.
24. Zimmerman, G. A., T. M. McIntyre, S. M. Prescott, and D. M. Stafforini. 2002. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit. Care Med. 30: S294-S301.
25. q in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. J. Immunol. 177: 3242-3249.
26. Lattin, J., D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet. 2007. G-protein-coupled receptor expression, function, and signaling in macrophages. J. Leukocyte Biol. 82: 16-32.
27. Lefkowitz, R. J., and S. K. Shenoy. 2005. Transduction of receptor signals by β-arrestins. Science 308: 512-517.
28. Chen, Z., D. J. Dupre, G. C. Le, M. Rola-Pleszczynski, and J. Stankova. 2002. Agonist-induced intemalization of the plalelet-activating factor receptor is dependent on arrestins but independent of G-protein activation: role of the C terminus and the (D/N)PXXY motif. J. Biol. Chan. 277: 7356-7362.
29. Silliman, C. C., K. L. Clay, G. W. Thurman, C. A. Johnson, and D. R. Ambruso. 1994. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J. Lab. Clin. Med. 124: 684-694.
30. Ambruso, D. R., B. G. Bolscher, P. M. Stokman, A. J. Verhoeven, and D. Roos. 1990. Assembly and activation of the NADPH:O2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate. J. Biol. Chem. 265: 924-930.
31. Giepmans, B. N., S. R. Adams, M. H. Ellisman, and R. Y. Tsien. 2006. The fluorescent toolbox for assessing protein location and function. Science 312: 217-224.
32. Dusi, S., M. Donini, and F. Rossi. 1996. Mechanisms of NADPH oxidase activation: translocation of p40phox, Rac1 and Rac2 from the cytosol to the membranes in human neutrophils lacking p47phox or p67phox. Biochem. J. 314: 409-412.
33. El, B. J., J. M. Ruedi, and B. M. Babior. 1994. Cytosolic guanine nucleotide-binding protein Rac2 operates in vivo as a component of the neutrophil respiratory burst oxidase: transfer of Rac2 and the cytosolic oxidase components p47phox and p67phox to the submembranous actin cytoskeleton during oxidase activation. J. Biol. Chem. 269: 6729-6734.
34. Kerkhoff, C., W. Nacken, M. Benedyk, M. C. Dagher, C. Sopalla, and J. Doussiere. 2005. The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J. 19: 467-469.
35. Monks, C. R., B. A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395: 82-86.
36. Yamamori, T., O. Inanami, H. Sumimoto, T. Akasaki, H. Nagahata, and M. Kuwabara. 2002. Relationship between p38 mitogen-activated protein kinase and small GTPase Rac for the activation of NADPH oxidase in bovine neutrophils. Biochem. Biophys. Res. Commun. 293: 1571-1578.
37. Weiner, O. D., G. Servant, M. D. Welch, T. J. Mitchison, J. W. Sedat, and H. R. Bourne. 1999. Spatial control of actin polymerization during neutrophil chemotaxis. Nat. Cell Biol. 1: 75-81.
38. Vogel, S. S., C. Thaler, and S. V. Koushik. 2006. Fanciful FRET. Sci. STKE 2006: re2.
39. Landmann, L., and P. Marbet. 2004. Colocalization analysis yields superior results after image restoration. Microsc. Res. Tech. 64: 103-112.
40. Bienz, K., D. Egger, and L. Pasamontes. 1986. Electron microscopic immuno-cytochemistry: silver enhancement of colloidal gold marker allows double labeling with the same primary antibody. J. Histochem. Cytochem. 34: 1337-1342.
41. Pickel, V. M., J. Chan, and D. Ganten. 1986. Dual peroxidase and colloidal gold-labeling study of angiotensin converting enzyme and angiotensin-like immunoreactivity in the rat subfomical organ. J. Neurosci. 6: 2457-2469.
42. Yi, H., J. Leunissen, G. Shi, C. Gutekunst, and S. Hersch. 2001. A novel procedure for pre-embedding double immunogold-silver labeling at the ultrastruc-tural level. J. Histochem. Cytochem. 49: 279-284.
43. Verkade, P., L. H. Schrama, A. J. Verkleij, W. H. Gispen, and A. B. Oestreicher. 1997. Ultrastructural co-localization of calmodulin and B-50/growth-associated protein-43 at the plasma membrane of proximal unmyelinated axon shafts studied in the model of the regenerating rat sciatic nerve. Neuroscience 79: 1207-1218.
44. Kranenburg, O., I. Verlaan, and W. H. Moolenaar. 1999. Gi-mediated tyrosine phosphorylation of Grb2 (growth-factor-receptor-bound protein 2)-bound dy-namin-II by lysophosphatidic acid. Biochem. J. 339: 11-14.
45. Miller, W. E., S. Maudsley, S. Ahn, K. D. Khan, L. M. Luttrell, and R. J. Lefkowitz. 2000. β-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC: role of β-arrestin1-dependent targeting of c-SRC in receptor endocytosis. J. Biol. Chem. 275: 11312-11319.
46. Callaghan, J., S. Nixon, C. Bucci, B. H. Toh, and H. Stenmark. 1999. Direct interaction of EEA1 with Rab5b. Eur. J. Biochem. 265: 361-366.
47. Su, X., I. J. Lodhi, A. R. Saltiel, and P. D. Stahl. 2006. Insulin-stimulated interaction between insulin receptor substrate 1 and p85α and activation of protein kinase B/Akt require Rab5. J. Biol. Chem. 281: 27982-27990.
48. Steele-Mortimer, O., J. Gruenberg, and M. J. Clague. 1993. Phosphorylation of GDI and membrane cycling of rab proteins. FEBS Lett. 329: 313-318.
49. Ullrich, O., H. Stenmark, K. Alexandrov, L. A. Huber, K. Kaibuchi, T. Sasaki, Y. Takai, and M. Zerial. 1993. Rab GDP dissociation inhibitor as a general regulator for the membrane association of rab proteins. J. Biol. Chem. 268: 18143-18150.
50. Cavalli, V., F. Vilbois, M. Corti, M. J. Marcote, K. Tamura, M. Karin, S. Arkinstall, and J. Gruenberg. 2001. The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex. Mol. Cell. 7: 421-432.
51. Chiariello, M., C. B. Bruni, and C. Bucci. 1999. The small GTPases Rab5a, Rab5b, and Rab5c are differentially phosphorylated in vitro. FEBS Lett. 453: 20-24.
52. Murph, M. M., L. A. Scaccia, L. A. Volpicelli, and H. Radhakrishna. 2003. Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway. J. Cell Sci. 116: 1969-1980.
53. Schmidlin, F., O. Dery, K. O. DeFea, L. Slice, S. Patierno, C. Sternini, E. F. Grady, and N. W. Bunnett. 2001. Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor. J. Biol. Chem. 276: 25427-25437.
54. Brown, G. E., M. Q. Stewart, H. Liu, V. L. Ha, and M. B. Yaffe. 2003. A novel assay system implicates PtdIns(3,4)P(2), PtdIns(3)P, and PKC delta in intracel-lular production of reactive oxygen species by the NADPH oxidase. Mol. Cell 11:35-47.
55. 558 II. Proc. Natl. Acad. Sci. USA 99: 4262-4265.
56. phox. J. Biol. Chem. 277: 10121-10128.
57. Leusen, J. H., K. Fluiter, P. M. Hilarius, D. Roos, A. J. Verhoeven, and B. G. Bolscher. 1995. Interactions between the cytosolic components p47phox and p67phox of the human neutrophil NADPH oxidase that are not required for activation in the cell-free system. J. Biol. Chem. 270: 11216-11221.
58. Kanai, F., H. Liu, S. J. Field, H. Akbary, T. Matsuo, G. E. Brown, L. C. Cantley, and M. B. Yaffe. 2001. The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nat. Cell Biol. 3: 675-678.
59. Ponting, C. P. 1996. Novel domains in NADPH oxidase subunits, sorting nexins, and PtdIns 3-kinases: binding gartners of SH3 domains? Protein Sci. 5: 2353-2357.
60. phox activates the NADPH oxidase during FcγIIA receptor-induced phagocytosis. J. Exp. Med. 203: 1915-1925.
61. phox PX domains of NADPH oxidase target cell membranes via direct and indirect recruitment by phosphoinositides. J. Biol. Chem. 277: 4512-4518.
62. 2+- depleted human neutrophils. Biochem. J. 290: 173-178.
63. Someya, A., H. Nunoi, T. Hasebe, and I. Nagaoka. 1999. Phosphorylation of p40-phox during activation of neutrophil NADPH oxidase. J. Leukocyte Biol. 66: 851-857.
64. Zhao, X., B. Xu, A. Bhattacharjee, C. M. Oldfield, F. B. Wientjes, G. M. Feldman, and M. K. Cathcart. 2005. Protein kinase Cδ regulates p67phox phosphorylation in human monocytes. J. Leukocyte Biol. 77: 414-420.
65. Cadwallader, K. A., A. M. Condliffe, A. McGregor, T. R. Walker, J. F. White, L. R. Stephens, and E. R. Chilvers. 2002. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. J. Immunol. 169: 3336-3344.
66. Dusi, S., and F. Rossi. 1993. Activation of NADPH oxidase of human neutrophils involves the phosphorylation and the translocation of cytosolic p67phox. Biochem. J. 296: 367-371.
67. Fuchs, A., A. P. Bouin, T. Rabilloud, and P. V. Vignais. 1997. The 40-kDa component of the phagocyte NADPH oxidase (p40phox) is phosphorylated during activation in differentiated HL60 cells. Eur. J. Biochem. 249: 531-539.
68. Sheppard, F. R., E. E. Moore, N. McLaughlin, M. Kelher, J. L. Johnson, and C. C. Silliman. 2005. Clinically relevant osmolar stress inhibits priming-induced PMN NADPH oxidase subunit translocation. J. Trauma 58: 752-757.
69. Diekmann, D., A. Abo, C. Johnston, A. W. Segal, and A. Hall. 1994. Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 265:531-533.
70. Heyworth, P. G., J. T. Curnutte, W. M. Nauseef, B. D. Volpp, D. W. Pearson, H. Rosen, and R. A. Clark. 1991. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly: translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J. Clin. Invest. 87: 352-356.
71. Ahn, S., J. Kim, C. L. Lucaveche, M. C. Reedy, L. M. Luttrell, R. J. Lefkowitz, and Y. Daaka. 2002. Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor. J. Biol. Chem. 277: 26642-26651.
72. Barbieri, M. A., R. L. Roberts, A. Gumusboga, H. Highfield, C. Varez-Dominguez, A. Wells, and P. D. Stahl. 2000. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J. Cell Biol 151: 539-550.
73. Merithew, E., C. Stone, S. Eathiraj, and D. G. Lambright. 2003. Determinants of Rab5 interaction with the N terminus of early endosome antigen 1. J. Biol. Chem. 278: 8494-8500.
74. Mills, I. G., S. Urbe, and M. J. Clague. 2001. Relationships between EEA1 binding partners and their role in endosome fusion. J. Cell Sci. 114: 1959-1965.
75. Roberts, R. L., M. A. Barbieri, J. Ullrich, and P. D. Stahl. 2000. Dynamics of rab5 activation in endocytosis and phagocytosis. J. Leukocyte Biol. 68: 627-632.
76. Vlahos, C. J., W. F. Matter, R. F. Brown, A. E. Traynor-Kaplan, P. G. Heyworth, E. R. Prossnitz, R. D. Ye, P. Marder, J. A. Schelm, and K. J. Rothfuss. 1995. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J. Immunol. 154: 2413-2422.
77. D'Adamo, P., A. Menegon, N. C. Lo, M. Grasso, M. Gulisano, F. Tamanini, T. Bienvenu, A. K. Gedeon, B. Oostra, S. K. Wu, et al. 1998. Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat. Genet. 19: 134-139.
78. Seabra, M. C., E. H. Mules, and A. N. Hume. 2002. Rab GTPases, intracellular traffic and disease. Trends Mol. Med. 8: 23-30.
79. Stenmark, H., R. G. Parton, O. Steele-Mortimer, A. Lutcke, J. Gruenberg, and M. Zerial. 1994. Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J. 13: 1287-1296.
80. Stenmark, II., A. Valencia, O. Martinez, O. Ullrich, B. Goud, and M. Zerial. 1994. Distinct structural elements of rab5 define its functional specificity. EMBO J. 13: 575-583.
81. 2-terminal kinase pathway in human neutrophils. J. Biol. Chem. 277: 40687-40696.
82. Nick, J. A., N. J. Avdi, S. K. Young, C. Knall, P. Gerwins, G. L. Johnson, and G. S. Worthen. 1997. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 99: 975-986.
83. Shin, H. W., M. Hayashi, S. Christoforidis, S. Lacas-Gervais, S. Hoepfner, M. R. Wenk, J. Modregger, S. Uttenweiler-Joseph, M. Wilm, A. Nystuen, et al. 2005. An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J. Cell Biol. 170: 607-618.
84. Vanhaesebroeck, B., S. J. Leevers, K. Ahmadi, J. Timms; R. Katso, P. C. Driscoll, R. Woscholski, P. J. Parker, and M. D. Waterfield. 2001. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70: 535-602.
85. Merino-Trigo, A., M. C. Kerr, F. Houghton, A. Lindberg, C. Mitchell, R. D. Teasdale, and P. A. Gleeson. 2004. Sorting nexin 5 is localized to a sub-domain of the early endosomes and is recruited to the plasma membrane following EGF stimulation. J. Cell Sci. 117: 6413-6424.
86. Sato, T. K., M. Overduin, and S. D. Emr. 2001. Location, location, location: membrane targeting directed by PX domains. Science 294: 1881-1885.
87. Simonsen, A., A. E. Wurmser, S. D. Emr, and H. Stenmark. 2001. The role of phosphoinositides in membrane transport. Curr. Opin. Cell Biol. 13: 485-492.
88. Zhong, Q., M. J. Watson, C. S. Lazar, A. M. Hounslow, J. P. Waltho, and G. N. Gill. 2005. Determinants of the endosomal localization of sorting nexin I. Mol. Biol. Cell 16: 2049-2057.
89. phox and mediates respiratory burst activity in human neutrophils. J. Immunol. 170: 5302-5308.
90. phox activity by site-specific phosphor-ylation: Akt-depcndent activation of the NADPH oxidase. Proc. Natl. Acad. Sci. USA 100: 5130-5135.
91. Sheppard, F. R., M. R. Kelher, E. E. Moore, N. J. McLaughlin, A. Banerjee, and C. C. Silliman. 2005. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J. Leukocyte Biol. 78: 1025-1042.